Home / Inspections / 1098218

FDA Inspection 1098218 — Novocol Pharmaceutical of Canada, Inc.

Novocol Pharmaceutical of Canada, Inc. — FEI 3002807757

The FDA completed an inspection of Novocol Pharmaceutical of Canada, Inc. on June 21, 2019 in Cambridge. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 21, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge (Canada)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1243223 (VAI Fri May 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117454 (NAI Thu Jan 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093310 (VAI Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019963 (VAI Wed Jul 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012538 (VAI Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources